Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion type Assertion NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_head.
- NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion wasGeneratedBy ECO_0000203 NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_provenance.
- NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion wasDerivedFrom befree-2016 NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_provenance.
- NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion SIO_000772 19417023 NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_provenance.
- NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion evidence source_evidence_literature NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_provenance.
- NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_assertion description "[Combined PCI-24781/bortezomib treatment resulted in strong synergistic apoptosis in all non-Hodgkin lymphoma lines (combination indices, 0.19-0.6) and was additive in Hodgkin lymphoma and primary CLL/SLL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736743.RADW7ho4bCZLvaLJymACW_mlOuCOl7K4JeD9mE2w26o60130_provenance.